International Journal of Basic & Clinical Pharmacology
The therapy of type 2 diabetes mellitus and obesity has been changed by glucagon-like peptide-1 receptor agonists (GLP-1 RAs). However, clinical evidences suggest their therapeutic
International Journal of Basic & Clinical Pharmacology
This is a narrative review article that surveys CRISPR technology, mechanisms, and potential applications without reporting original empirical data, clinical outcomes, or evidence synthesis from trials.